Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.88 and traded as high as $2.18. Organicell Regenerative Medicine shares last traded at $2.10, with a volume of 11,048 shares changing hands.
Organicell Regenerative Medicine Trading Down 5.7%
The business has a fifty day moving average price of $1.88 and a 200 day moving average price of $2.15.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Further Reading
- Five stocks we like better than Organicell Regenerative Medicine
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
